OBI-868


OBI-868

Glycan Array

A carbohydrate membrane array test reagent that can instantly monitor the concentration of carbohydrate antibodies generated in a patient, OBI-868 is a carbohydrate membrane array that offers greater sensitivity, specificity, and accuracy than the traditional ELISA method. This array has been used for specimen analysis in the clinical trial setting, including the OBI-822 retrospective trial and OBI-833 Phase I clinical trial. Preliminary experimental data indicates that patients who generate enough Globo H IgG antibodies at an early stage will benefit with better PFS. In the future, OBI-868 may be used to assist the Company in relevant tests necessary for the development of carbohydrate-based active immuno-oncology therapies.